Single-agent daratumumab in patients with relapsed and refractory multiple myeloma requiring dialysis: results of a Spanish retrospective, multicentre study

被引：15

作者：

Cejalvo, Maria J. ^{[1
]}

Legarda, Mario ^{[1
]}

Abella, Eugenia ^{[2
]}

Cabezudo, Elena ^{[3
]}

Encinas, Cristina ^{[4
]}

Garcia-Feria, Ana ^{[5
]}

Gironella, Mercedes ^{[6
]}

Inigo, Belen ^{[7
]}

Martin, Jesus ^{[8
]}

Ribas, Paz ^{[1
]}

Angeles Ruiz, Ma ^{[9
]}

Gonzalez, Yolanda ^{[10
]}

Vicuna, Isabel ^{[11
]}

Ramirez, Angel ^{[12
]}

Fernandez, Pascual ^{[13
]}

de la Rubia, Javier ^{[1
,14
]}

机构：

[1] Univ Hosp Doctor Peset, Dept Hematol, Valencia, Spain

[2] Hosp del Mar, Dept Hematol, Barcelona, Spain

[3] Hosp St Joan de Deu, Dept Hematol, Barcelona, Spain

[4] Hosp Gregorio Maranon, Dept Hematol, Madrid, Spain

[5] Hosp Manises, Dept Hematol, Valencia, Spain

[6] Hosp Valle De Hebron, Dept Hematol, Barcelona, Spain

[7] Hosp Clin San Carlos, Dept Hematol, Madrid, Spain

[8] Hosp Virgen del Rocio, Dept Hematol, Seville, Spain

[9] Hosp Francesc Borja, Dept Hematol, Gandia, Spain

[10] Inst Catalan Oncol, Dept Hematol, Girona, Spain

[11] Hosp La Princesa, Dept Hematol, Madrid, Spain

[12] Hosp Cent Asturias, Dept Hematol, Oviedo, Spain

[13] Hosp Gen, Dept Hematol, Alicante, Spain

[14] Catholic Univ Valencia, Sch Med & Dent, Internal Med, Valencia, Spain

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2020年 / 190卷 / 05期

关键词：

daratumumab; dialysis; multiple myeloma; relapse; DOSE DEXAMETHASONE; RENAL-FAILURE; BORTEZOMIB; SAFETY;

D O I：

10.1111/bjh.16286

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E289 / E292

页数：4

共 15 条

[1] Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: a multicenter retrospective study [J].

Chanan-Khan, Asher A. ;

Kaufman, Jonathan L. ;

Mehta, Jayesh ;

Richardson, Paul G. ;

Miller, Kena C. ;

Lonial, Sagar ;

Munshi, Nikhil C. ;

Schlossman, Robert ;

Tariman, Joseph ;

Singhal, Seema .

BLOOD, 2007, 109 (06) :2604-2606

[2]

CHAVAZ A, 1976, NOUV PRESSE MED, V5, P565

[3] Activity and safety of lenalidomide and dexamethasone in patients with multiple myeloma requiring dialysis: a Spanish multicenter retrospective study [J].

de la Rubia, Javier ;

Roig, Monica ;

Ibanez, Angela ;

Garcia, Inmaculada ;

Vera, Jose A. ;

Aguilar, Carlos ;

del Campo, Raquel ;

Gonzalez, Nicolas ;

Martinez, Rafael ;

Palomera, Luis ;

Picon, Isabel ;

Rodriguez, Juan N. ;

Sanz, Miguel A. .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 85 (04) :363-365

[4] Pomalidomide Plus Low-Dose Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and Renal Impairment: Results From a Phase II Trial [J].

Dimopoulos, Meletios ;

Weisel, Katja ;

van de Donk, Niels W. C. J. ;

Ramasamy, Karthik ;

Gamberi, Barbara ;

Streetly, Matthew ;

Offidani, Massimo ;

Bridoux, Frank ;

de la Rubia, Javier ;

Mateos, Maria-Victoria ;

Ardizzoia, Antonio ;

Kueenburg, Elisabeth ;

Collins, Shona ;

Di Micco, Antonia ;

Rosettani, Barbara ;

Li, Yan ;

Bacon, Pamela ;

Sonneveld, Pieter .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (20) :2035-+

[5] Renal Impairment in Patients With Multiple Myeloma: A Consensus Statement on Behalf of the International Myeloma Working Group [J].

Dimopoulos, Meletios A. ;

Terpos, Evangelos ;

Chanan-Khan, Asher ;

Leung, Nelson ;

Ludwig, Heinz ;

Jagannath, Sundar ;

Niesvizky, Ruben ;

Giralt, Sergio ;

Fermand, Jean-Paul ;

Blade, Joan ;

Comenzo, Raymond L. ;

Sezer, Orhan ;

Palumbo, Antonio ;

Harousseau, Jean-Luc ;

Richardson, Paul G. ;

Barlogie, Bart ;

Anderson, Kenneth C. ;

Sonneveld, Pieter ;

Tosi, Patrizia ;

Cavo, Michele ;

Rajkumar, S. Vincent ;

Durie, Brian G. M. ;

San Miguel, Jesus .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (33) :4976-4984

[6] Presentation and survival of patients with severe acute kidney injury and multiple myeloma: a 20-year experience from a single centre [J].

Haynes, Richard J. ;

Read, Simon ;

Collins, Graham P. ;

Darby, Sarah C. ;

Winearls, Christopher G. .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (02) :419-426

[7] Infectious and immunological sequelae of daratumumab in multiple myeloma [J].

Johnsrud, Andrew J. ;

Johnsrud, Joyce J. ;

Susanibar, Sandra A. ;

Kamimoto, Jorge J. ;

Kothari, Atul ;

Burgess, Mary ;

Van Rhee, Frits ;

Rico, Juan C. .

BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (01) :187-189

[8] Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone-containing regimens and the impact of novel agents [J].

Kastritis, Efstathios ;

Anagnostopoulos, Athanasios ;

Roussou, Maria ;

Gika, Dimitra ;

Matsouka, Charis ;

Barmparousi, Despina ;

Grapsa, Irini ;

Psimenou, Erasmia ;

Bamias, Aristotle ;

Dimopoulos, Meletios Athanasios .

HAEMATOLOGICA, 2007, 92 (04) :546-549

[9] Multiple myeloma [J].

Korbet, Stephen M. ;

Schwartz, Melvin M. .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (09) :2533-2545

[10] Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma [J].

Mateos, M. -V. ;

Dimopoulos, M. A. ;

Cavo, M. ;

Suzuki, K. ;

Jakubowiak, A. ;

Knop, S. ;

Doyen, C. ;

Lucio, P. ;

Nagy, Z. ;

Kaplan, P. ;

Pour, L. ;

Cook, M. ;

Grosicki, S. ;

Crepaldi, A. ;

Liberati, A. M. ;

Campbell, P. ;

Shelekhova, T. ;

Yoon, S. -S. ;

Iosava, G. ;

Fujisaki, T. ;

Garg, M. ;

Chiu, C. ;

Wang, J. ;

Carson, R. ;

Crist, W. ;

Deraedt, W. ;

Nguyen, H. ;

Qi, M. ;

San-Miguel, J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (06) :518-528

← 1 2 →